{"id":"https://openalex.org/W3136280736","doi":"https://doi.org/10.1161/str.52.suppl_1.p808","title":"Abstract P808: The Main Peptide Ssubstrates of Neurolysin Enhance Brain Microvascular Permeability in a Human in vitro Model","display_name":"Abstract P808: The Main Peptide Ssubstrates of Neurolysin Enhance Brain Microvascular Permeability in a Human in vitro Model","publication_year":2021,"publication_date":"2021-03-01","ids":{"openalex":"https://openalex.org/W3136280736","doi":"https://doi.org/10.1161/str.52.suppl_1.p808","mag":"3136280736"},"language":"en","primary_location":{"id":"doi:10.1161/str.52.suppl_1.p808","doi":"https://doi.org/10.1161/str.52.suppl_1.p808","is_oa":false,"landing_page_url":"https://doi.org/10.1161/str.52.suppl_1.p808","pdf_url":null,"source":{"id":"https://openalex.org/S62532593","display_name":"Stroke","issn_l":"0039-2499","issn":["0039-2499","1524-4628"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stroke","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057900193","display_name":"Abraham Jacob Al-Ahmad","orcid":"https://orcid.org/0000-0001-7463-3204","observed_orcids":["https://orcid.org/0000-0001-7463-3204"]},"institutions":[{"id":"https://openalex.org/I12315562","display_name":"Texas Tech University","ror":"https://ror.org/0405mnx93","country_code":"US","type":"education","lineage":["https://openalex.org/I12315562"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abraham Al-Ahmad","raw_affiliation_strings":["Pharmaceutical Sciences, TEXAS TECH, Amarillo, TX","Abraham Al-Ahmad Pharmaceutical Sciences, TEXAS TECH, Amarillo, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, TEXAS TECH, Amarillo, TX","institution_ids":["https://openalex.org/I12315562"]},{"raw_affiliation_string":"Abraham Al-Ahmad Pharmaceutical Sciences, TEXAS TECH, Amarillo, TX","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037761449","display_name":"Vardan T. Karamyan","orcid":"https://orcid.org/0000-0003-0050-6047","observed_orcids":["https://orcid.org/0000-0003-0050-6047"]},"institutions":[{"id":"https://openalex.org/I12315562","display_name":"Texas Tech University","ror":"https://ror.org/0405mnx93","country_code":"US","type":"education","lineage":["https://openalex.org/I12315562"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vardan T Karamyan","raw_affiliation_strings":["TEXAS TECH, Amarillo, TX","Vardan T Karamyan TEXAS TECH, Amarillo, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TEXAS TECH, Amarillo, TX","institution_ids":["https://openalex.org/I12315562"]},{"raw_affiliation_string":"Vardan T Karamyan TEXAS TECH, Amarillo, TX","institution_ids":["https://openalex.org/I12315562"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I12315562"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"52","issue":"Suppl_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10706","display_name":"Traumatic Brain Injury and Neurovascular Disturbances","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11763","display_name":"Intracerebral and Subarachnoid Hemorrhage Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neurolysin","display_name":"neurolysin","score":0.9919999837875366},{"id":"https://openalex.org/keywords/blood-brain-barrier-permeability","display_name":"blood-brain barrier permeability","score":0.8379999995231628},{"id":"https://openalex.org/keywords/brain-microvascular-endothelial-cells","display_name":"brain microvascular endothelial cells","score":0.8420000076293945},{"id":"https://openalex.org/keywords/bradykinin","display_name":"bradykinin","score":0.8920000195503235},{"id":"https://openalex.org/keywords/neurotensin","display_name":"neurotensin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/substance-p","display_name":"substance P","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ischemic-stroke","display_name":"ischemic stroke","score":0.8870000243186951},{"id":"https://openalex.org/keywords/ipsc-derived-endothelial-cells","display_name":"iPSC-derived endothelial cells","score":0.9229999780654907},{"id":"https://openalex.org/keywords/neuropeptide-processing","display_name":"neuropeptide processing","score":0.6610000133514404},{"id":"https://openalex.org/keywords/receptor-antagonists","display_name":"receptor antagonists","score":0.5180000066757202},{"id":"https://openalex.org/keywords/brain-protection","display_name":"cerebral protection","score":0.5580000281333923}],"concepts":[{"id":"https://openalex.org/C2778976297","wikidata":"https://www.wikidata.org/wiki/Q419576","display_name":"Neurotensin","level":4,"score":0.8589743375778198},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6504709124565125},{"id":"https://openalex.org/C2779591629","wikidata":"https://www.wikidata.org/wiki/Q24745328","display_name":"Bradykinin","level":3,"score":0.6383543610572815},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.6295571327209473},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.6233555674552917},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5637720227241516},{"id":"https://openalex.org/C120882062","wikidata":"https://www.wikidata.org/wiki/Q28352","display_name":"Permeability (electromagnetism)","level":3,"score":0.4879435896873474},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.44864189624786377},{"id":"https://openalex.org/C28406088","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Extracellular","level":2,"score":0.43951335549354553},{"id":"https://openalex.org/C118303440","wikidata":"https://www.wikidata.org/wiki/Q419968","display_name":"Neuropeptide","level":3,"score":0.43483811616897583},{"id":"https://openalex.org/C113045295","wikidata":"https://www.wikidata.org/wiki/Q7916465","display_name":"Vascular permeability","level":2,"score":0.411876916885376},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.34811192750930786},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2507411241531372},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2091737687587738},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17212331295013428},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.13412553071975708},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.08853334188461304}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1161/str.52.suppl_1.p808","doi":"https://doi.org/10.1161/str.52.suppl_1.p808","is_oa":false,"landing_page_url":"https://doi.org/10.1161/str.52.suppl_1.p808","pdf_url":null,"source":{"id":"https://openalex.org/S62532593","display_name":"Stroke","issn_l":"0039-2499","issn":["0039-2499","1524-4628"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stroke","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3121900526","https://openalex.org/W4396850140","https://openalex.org/W4377029159","https://openalex.org/W4387609313","https://openalex.org/W7083221242","https://openalex.org/W3048904126","https://openalex.org/W2971633026","https://openalex.org/W2911230940","https://openalex.org/W3176063052","https://openalex.org/W2071055186"],"abstract_inverted_index":{"Increased":[0],"brain":[1,33,89],"microvascular":[2,90],"permeability":[3,113,139,179,219,250],"and":[4,27,49,62,67,94,110,156,158,168,191,251],"disruption":[5],"of":[6,14,41,55,59,76,84,98,107,114,165,188,196,206,220,227,246,257,271],"blood-brain":[7],"barrier":[8],"(BBB)":[9],"function":[10],"are":[11],"among":[12],"hallmarks":[13],"ischemic":[15],"stroke.":[16],"Recently,":[17],"peptidase":[18,265],"neurlysin":[19],"(Nln)":[20],"has":[21],"been":[22],"identified":[23],"as":[24],"a":[25,38,141,171],"compensatory":[26],"cerebroprotective":[28],"mechanism":[29],"in":[30,64,78,116,118,140,144,146,176,180,204,222,229,231],"the":[31,81,88,104,181,212,239,254,269],"post-stroke":[32],"that":[34,133,264],"functions":[35],"to":[36,80,102,216,224,253],"process":[37],"diverse":[39],"group":[40],"extracellular":[42],"neuropeptides,":[43],"including":[44],"bradykinin":[45],"(BK),":[46],"neurotensin":[47],"(NT)":[48],"substance":[50],"P":[51],"(SP).":[52],"A":[53],"number":[54],"studies":[56],"suggest":[57],"involvement":[58],"BK,":[60,108,166,189],"NT":[61,109,167,190,228],"SP":[63,111,169,192,247],"BBB":[65,115,138,178,221,249],"impairment":[66],"edema":[68],"formation":[69],"after":[70],"stroke,":[71],"however":[72],"there":[73],"is":[74,211],"paucity":[75],"data":[77,131],"regards":[79],"direct":[82,105,225,244],"effects":[83,106,193,270],"these":[85,272],"peptides":[86,136,273],"on":[87,112,122,248,259,274],"endothelial":[91],"cells":[92],"(BMECs)":[93],"BBB.":[95,260],"The":[96],"purpose":[97],"this":[99],"study":[100,215,237],"was":[101],"evaluate":[103],"an":[117,145,230],"vitro":[119,147,232],"model":[120,148],"based":[121],"human,":[123],"induced":[124],"pluripotent":[125],"stem":[126],"cell":[127],"(iPSC)-derived":[128],"BMECs.":[129,163],"Our":[130],"indicate":[132],"all":[134],"three":[135],"increase":[137],"concentration-dependent":[142],"manner":[143],"formed":[149],"from":[150],"two":[151],"different":[152],"iPSC":[153],"lines":[154],"(CTR90F":[155],"CTR65M)":[157],"widely":[159],"used":[160],"hCMEC/D3":[161],"human":[162],"Combination":[164],"at":[170],"sub-effective":[172],"concentration":[173],"also":[174],"resulted":[175],"increased":[177,218],"iPSC-derived":[182],"model.":[183,233],"Furthermore,":[184],"we":[185,262],"observed":[186],"abrogation":[187],"with":[194],"pretreatment":[195],"pharmacological":[197],"blockers":[198],"targeting":[199],"their":[200],"specific":[201],"receptors":[202],"or":[203],"presence":[205],"recombinant":[207],"neurolysin":[208],"(Nln).":[209],"This":[210],"first":[213],"experimental":[214],"document":[217],"response":[223],"action":[226],"In":[234],"addition,":[235],"our":[236],"confirms":[238],"expected":[240],"but":[241],"not":[242],"well-documented,":[243],"effect":[245],"adds":[252],"well-recognized":[255],"actions":[256],"BK":[258],"Lastly,":[261],"demonstrate":[263],"Nln":[266],"can":[267],"neutralize":[268],"BBB,":[275],"suggesting":[276],"potential":[277],"therapeutic":[278],"implications.":[279]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-03-29T00:00:00"}